People in the News: Jonathan Lord | GenomeWeb

Jonathan Lord has been named to Vigilant Biosciences' board of directors. Lord was previously CEO at Navigenics and currently serves as the chair of the board of directors of Dexcom, director at Stericycle, and on the advisory board of Serco, Anthello Health, and Third Rock Ventures.

Additionally, he is chief operating officer of the University of Miami's Miller School of Medicine and a professor of pathology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.